PDCD1 and cancer: Given that γδ T cells have received relatively limited attention in the context of ICB, we conducted a comprehensive analysis of peripheral blood and tumor tissue samples from patients with late-stage melanoma undergoing PD-1 blockade, aiming to obtain novel insights into the complex network of ICB modulation of cancer immunosurveillance.